David Quan

Clinical pharmacist

David Quan serves as a clinical pharmacist for the Intestinal Rehabilitation and Transplant program, as well as the Liver Transplant program at UCSF Medical Center. In addition to caring for patients, he also holds the position of associate clinical professor of pharmacy at UCSF, where he provides didactic and experiential teaching for pharmacy students and residents in pharmacy practice.

Quan is the author of various publications regarding transplant immunosuppression, aspects of liver disease and pharmacotherapy. He also is the author of several textbook chapters and serves as a senior editor of the Textbook of Therapeutics: Drug and Disease Management. Quan received his doctor of pharmacy and completed a residency in clinical pharmacy at UCSF.


Liver Transplant Program
400 Parnassus Ave., Seventh Floor
San Francisco, CA 94143
Phone: (415) 353-1888
Fax: (415) 353-8917

Hours: Pre-Liver Transplant Clinic Monday, Tuesday, Wednesday 7 a.m. – 12 p.m.
Hours: Post-Liver Transplant Clinic Tuesday 8 a.m. – 12 p.m., Thursday 1-4 p.m.

Selected Research and Publications

  1. Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation. 2017 Sep; 101(9):2079-2082.
  2. Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hosp Pharm. 2013 Apr; 48(4):302-7.
  3. Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl. 2013 Apr; 19(4):457-61.
  4. Dong K, Quan DJ. Appropriately assessing renal function for drug dosing. Nephrol Nurs J. 2010 May-Jun; 37(3):304-8.
  5. Quan DJ. Pharmacotherapy of hepatitis C virus infection: a brief review. Nephrol Nurs J. 2009 May-Jun; 36(3):333-7.
  6. Quan DJ. A brief history in nephrology pharmacotherapy. Nephrol Nurs J. 2009 Mar-Apr; 36(2):223-7.
  7. Quan DJ. Pharmacotherapy of hepatitis B infection: a brief review. Nephrol Nurs J. 2008 Sep-Oct; 35(5):507-10, 534.
  8. Quan DJ. A primer on pharmacokinetics. Nephrol Nurs J. 2008 Mar-Apr; 35(2):213-5.
  9. Niemann CU, Behrends M, Quan D, Eilers H, Gropper MA, Roberts JP, Hirose R. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med. 2006 Apr; 16(2):93-100.
  10. Quan DJ, Peters MG. Antiviral therapy: nucleotide and nucleoside analogs. Clin Liver Dis. 2004 May; 8(2):371-85.
  11. Reinus JF, Persky S, Burkiewicz JS, Quan D, Bass NM, Davern TJ. Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intern Med. 2000 Dec 19; 133(12):964-8.
  12. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl. 2000 Nov; 6(6):734-40.
  13. Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation. 2000 Jan 27; 69(2):307-11.
  14. Quan DJ, Kayser SR. Ketorolac induced acute renal failure following a single dose. J Toxicol Clin Toxicol. 1994; 32(3):305-9.
  15. Quan DJ, McQueen KD. dDAVP in enuresis. DICP. 1990 Dec; 24(12):1179-80.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.

This health care professional is not a member of UCSF Medical Group. Please check with your health insurance plan regarding coverage for services.